Home » Stocks » NDRA

ENDRA Life Sciences Inc. (NDRA)

Stock Price: $2.18 USD -0.04 (-1.80%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
Market Cap 90.69M
Revenue (ttm) n/a
Net Income (ttm) -12.12M
Shares Out 41.60M
EPS (ttm) -0.63
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $2.18
Previous Close $2.22
Change ($) -0.04
Change (%) -1.80%
Day's Open 2.20
Day's Range 2.07 - 2.23
Day's Volume 772,740
52-Week Range 0.60 - 3.10

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Here are a few MedTech stocks, Natus Medical (NTUS), Owens & Minor (OMI), ENDRA Life Sciences (NDRA), Penumbra (PEN), Apollo Medical (AMEH), which might be prudent investment choices now.

Other stocks mentioned: ABT, AMEH, HSIC, NTUS, OMI, PEN
2 days ago - Zacks Investment Research

ANN ARBOR, MI / ACCESSWIRE / April 8, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the Company's Chief Technolog...

1 week ago - Accesswire

Conference call begins at 4:30 p.m. Eastern time today ANN ARBOR, MI / ACCESSWIRE / March 25, 2021 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (T...

3 weeks ago - Accesswire

Hepion to include ENDRA's TAEUS Ⓡ technology in Phase 2b trial of CRV431 ANN ARBOR, MI and EDISON, NJ / ACCESSWIRE / March 18, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic...

Other stocks mentioned: HEPA
1 month ago - Accesswire

ANN ARBOR, MI / ACCESSWIRE / March 17, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial result...

1 month ago - Accesswire

ANN ARBOR, MI / ACCESSWIRE / March 2, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in two ...

1 month ago - Accesswire

Now Has 78 Patents Issued, Filed, Licensed or in Preparation As Taeus® Commercial Launch Plans Advance ANN ARBOR, MI / ACCESSWIRE / January 13, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a p...

3 months ago - Accesswire

ANN ARBOR, MI / ACCESSWIRE / January 8, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that Chairman and CEO Francois Michelo...

3 months ago - Accesswire

ANN ARBOR, MI / ACCESSWIRE / December 23, 2020 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), has recently been issued Chinese Patent ZL 201...

3 months ago - Accesswire

Supports Commercialization of TAEUS Ⓡ Product for Imaging NAFLD/NASH to December 2023 ANN ARBOR, MI / ACCESSWIRE / December 21, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Ther...

3 months ago - Accesswire

ANN ARBOR, MI / ACCESSWIRE / December 18, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a developer of enhanced ultrasound technologies, today reported the closing of its previously announced...

4 months ago - Accesswire

ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

ENDRA Life Sciences Inc.'s (NDRA) CEO Francois Michelon on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

TAEUS device fills the need for a non-invasive test for NASH.

9 months ago - Seeking Alpha

ENDRA Life Sciences, Inc. (NDRA) CEO Francois Michelon on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

ENDRA Life Sciences, Inc. (NDRA) CEO Francois Michelon on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

ENDRA Life Sciences, Inc. (NDRA) CEO Francois Michelon on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

ENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

ENDRA released data at the end of 2019Q1 that didn't live up to the market's expectation, sending its share price down to new lows.

1 year ago - Seeking Alpha

ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q1 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

About NDRA

ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. It develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. The company also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body ... [Read more...]

Industry
Diagnostics & Research
IPO Date
May 9, 2017
Stock Exchange
NASDAQ
Ticker Symbol
NDRA
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for NDRA stock is "Strong Buy." The 12-month stock price forecast is 5.75, which is an increase of 163.76% from the latest price.

Price Target
$5.75
(163.76% upside)
Analyst Consensus: Strong Buy